NCT07292922 Digital-supported Orofacial Myofunctional Therapy in OSA
| NCT ID | NCT07292922 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Metropolitan University |
| Condition | Obstructive Sleep Apnea (OSA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-05 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity. Participants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30). Feasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and above * Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour * Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments * Body Mass Index less than 30 kg/m2 Exclusion Criteria: * Presence of obstructive nasal disease or significant nasal obstruction * Unstable mental health issues * History of stroke * Unstable chronic respiratory, cardiac, neurological conditions * Inability to provide informed consent * Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea
Contact & Investigator
Agnes YK Lai, PhD
PRINCIPAL INVESTIGATOR
Hong Kong Metropolitan University
Frequently Asked Questions
Who can join the NCT07292922 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Obstructive Sleep Apnea (OSA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07292922 currently recruiting?
Yes, NCT07292922 is actively recruiting participants. Contact the research team at ayklai@hkmu.edu.hk for enrollment information.
Where is the NCT07292922 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong.
Who is sponsoring the NCT07292922 clinical trial?
NCT07292922 is sponsored by Hong Kong Metropolitan University. The principal investigator is Agnes YK Lai, PhD at Hong Kong Metropolitan University. The trial plans to enroll 60 participants.